市场调查报告书
商品编码
1466582
胶囊内视镜市场:依产品、应用和最终用途 – 2024-2030 年全球预测Capsule Endoscopy Market by Product (Capsule Endoscopes, Systems), Application (Crohn's Disease, Obscure Gastrointestinal Bleeding, Small Intestine Tumor), End-Use - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年胶囊内视镜市场规模为5.5466亿美元,2024年将达到6.0657亿美元,2030年将达到10.6737亿美元,复合年增长率为9.80%。
胶囊内视镜是一种现代诊断工具,可以使用配备摄影机的锭剂大小的胶囊对胃肠道进行可视化和检查。该市场由製造商、医疗保健提供者和使用这些设备进行胃肠道诊断的患者组成。全球胃肠道疾病盛行率的不断上升以及微创手术干预措施的大量采用,为市场成长做出了积极贡献。与胶囊滞留、副作用和小肠测试结果不完整相关的担忧是市场的主要障碍。这个市场的机会包括不断改善医疗基础设施和提高对胃肠道疾病的认识的倡议。除了技术进步之外,设计更好的无线胶囊预计将推动市场成长。
主要市场统计 | |
---|---|
基准年[2023] | 55466万美元 |
预测年份 [2024] | 60657万美元 |
预测年份 [2030] | 10.6737 亿美元 |
复合年增长率(%) | 9.80% |
由于微创产品,胶囊内视镜的采用范围不断扩大
胶囊内视镜是一种小型相机,其大小与患者吞嚥的锭剂大小相同。这些设备穿过胃肠道,拍摄影像并无线传输以进行医疗诊断。它是首选,因为它可以使小肠可视化,这是传统内视镜难以到达的。患者选择胶囊内视镜检查是因为它是微创且不需要镇静。手术简便且无不适感是其主要优点,也适合儿童和老年患者。胶囊内视镜所使用的系统是指记录、检视和分析胶囊内视镜所捕捉的资料所需的硬体和软体。这样的系统由工作站、资料记录器、接收带和影像分析软体所组成。这些对于收集和管理胶囊内视镜检查产生的大量资料至关重要。先进的软体有助于详细检查影像并支援更好的诊断。使用者友善的介面因其简化内视镜检查过程而受到医疗保健提供者的重视。
应用 扩大胶囊内视镜在不明原因消化道出血(OGIB) 治疗的应用
克隆氏症是一种发炎性肠道疾病(IBD),可影响胃肠道的任何部位。胶囊内视镜在诊断和评估克隆氏症的程度和活动性方面特别有用,因为它可以可视化传统内视镜难以到达的小肠区域。胶囊内视镜是非侵入性的,使其成为对患者更友善的选择,可以持续监测疾病进展和治疗反应。不明原因消化道出血(OGIB)是指胃肠道内不明原因的出血。胶囊内视镜检查对于诊断 OGIB 极为重要,因为它可以检测传统内视镜检查或大肠镜检查无法发现的小肠内出血来源。小肠肿瘤的诊断是胃肠病学的一个挑战,因为传统的内视镜设备进入小肠的途径有限。胶囊内视镜是检查小肠良性和恶性的重要工具。它有助于早期诊断,并在其他影像检查无法提供足够的可视性或结论性结果时发挥重要作用。胶囊内视镜的偏好很大程度上取决于进入和可视化小肠远处区域的能力。克隆氏症的长期后续观察至关重要,而 OGIB 则优先考虑确定出血来源的急性诊断能力。对于小肠肿瘤,早期、准确的检测非常重要。
最终用途:在医院中越来越多地使用案例胶囊内视镜来处理需要多学科方法的复杂病例
门诊手术中心是提供当天手术治疗的医疗机构,包括诊断和预防程序。 ASC 越来越受到胶囊内视镜检查的青睐,因为它们不需要住院并提供方便且具有成本效益的服务。 ASC 因其患者周转快、院内感染风险低以及提供专业护理的能力而受到青睐。医院是各种内视镜手术(包括胶囊内视镜检查)的主要场所。对于需要多学科方法或需要紧急干预的复杂病例,医院是首选。该医院拥有广泛的基础设施,包含各种诊断和治疗服务,如果需要进一步治疗,则结合胶囊内视镜检查治疗结果进行。
区域洞察
在美洲,受先进的医疗基础设施、研发和胃肠道疾病高盛行率的推动,美国是胶囊内视镜的领先市场。胶囊内视镜的采用得到了其他地区不常见的优惠报销政策的支持。由于医疗保健支出和技术采用率的差异,加拿大和南美国家也对市场做出了轻微贡献。亚太地区胶囊内视镜市场正在快速成长,这主要是由于人口老化的加剧、医疗基础设施的改善以及胃肠道疾病发病率的增加。日本、韩国和中国等国家处于领先地位,其中日本因其创新的医疗保健系统而成为胶囊内视镜技术的较早采用者。欧洲、中东和非洲 (EMEA) 地区呈现出多元化的胶囊内视镜市场。西欧国家拥有成熟的医疗保健部门,有强大的医疗保健系统和广泛的保险计划支持,并且胶囊内视镜等新诊断技术的采用率很高。在中东国家,由于医疗投资的增加和医疗设施的现代化,对医疗保健服务和医疗设备(包括胶囊内视镜)的需求正在增加。
FPNV定位矩阵
FPNV定位矩阵对于评估胶囊内视镜市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对胶囊内视镜市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4.竞争力评估及资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.胶囊内视镜市场规模及预测如何?
2.在胶囊内视镜市场预测期间内,有哪些产品、细分市场、应用和领域需要考虑投资?
3.胶囊内视镜市场的技术趋势和法规结构是什么?
4.胶囊内视镜市场主要厂商的市场占有率如何?
5.进入胶囊内视镜市场的合适型态和策略手段是什么?
[196 Pages Report] The Capsule Endoscopy Market size was estimated at USD 554.66 million in 2023 and expected to reach USD 606.57 million in 2024, at a CAGR 9.80% to reach USD 1,067.37 million by 2030.
Capsule endoscopy is a modern diagnostic tool that allows for the visualization and examination of the gastrointestinal tract using a pill-sized capsule equipped with a camera. This market comprises manufacturers, healthcare providers, and patients utilizing the device for gastrointestinal diagnosis. The increasing prevalence of gastrointestinal disorders globally and the significant adoption of minimally invasive surgical interventions contribute positively to market growth. Concerns associated with capsule retention rate, adverse effects, and incomplete small bowl examination results are significant hindrances in markets. Opportunities within this market involve growing initiatives to improve healthcare infrastructure and increase awareness of gastrointestinal disorders. In addition, technological advancements coupled with better-designed wireless capsules are expected to create growth in the market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 554.66 million |
Estimated Year [2024] | USD 606.57 million |
Forecast Year [2030] | USD 1,067.37 million |
CAGR (%) | 9.80% |
Product: Growing adoption of capsule endoscopes due to their minimally invasive nature
Capsule endoscopes are tiny, pill-sized cameras that patients swallow. These devices travel through the gastrointestinal tract, capturing images and sending them wirelessly for medical diagnosis. These are preferred for their ability to visualize the small intestine, an area that is difficult to reach with traditional endoscopes. Patients opt for capsule endoscopes due to their minimally invasive nature, with no need for sedation. The ease of the procedure and the lack of discomfort are significant benefits, making it suitable for children and elderly patients. Systems in the context of capsule endoscopy include the necessary supporting hardware and software used to record, view, and analyze the data captured by the capsule endoscopes. Such systems consist of workstations, data recorders, receiver belts, and software for image analysis. These are critical for collecting and managing the vast amounts of data generated by capsule endoscopes. Advanced software helps in the detailed examination of images and supports better diagnosis. User-friendly interfaces are valued by healthcare providers for streamlining the endoscopic process.
Application: Expanding usage of capsule endoscopes for managing obscure gastrointestinal bleeding (OGIB)
Crohn's disease is a type of inflammatory bowel disease (IBD) that affects any part of the gastrointestinal tract. Capsule endoscopy is particularly beneficial in diagnosing and assessing the extent and activity of Crohn's disease, as it can visualize areas of the small intestine that are difficult to reach with traditional endoscopy procedures. The non-invasive nature of capsule endoscopy provides a more patient-friendly option for continuous monitoring of disease progression or response to therapy. Obscure gastrointestinal bleeding (OGIB) refers to bleeding that occurs from an unknown source in the gastrointestinal tract. Capsule endoscopy is critical in diagnosing OGIB, as it can detect bleeding sources in the small intestine that are not visible through traditional endoscopy or colonoscopy. Small intestine tumor diagnosis is a challenging area in gastrointestinal medicine due to the limited accessibility of the small intestine with conventional endoscopic equipment. Capsule endoscopy is a crucial tool in detecting benign and malignant tumors within the small intestine. It helps in early diagnosis and plays a vital role where other imaging studies don't provide adequate visibility or conclusive results. The preference for capsule endoscopy is shaped largely by its ability to access and visualize remote parts of the small bowel. With Crohn's Disease, the long-term monitoring aspect is paramount, while in OGIB, the acute diagnostic capability to identify the source of bleeding is the priority. For small intestine tumors, the emphasis is on early and accurate detection.
End-Use: Increasing usage of capsule endoscopes by hospitals for more complicated cases that require a multi-disciplinary approach
Ambulatory surgery centers are healthcare facilities that provide same-day surgical care, including diagnostic and preventive procedures. ASCs are increasingly preferred for capsule endoscopy because they offer convenient and cost-effective services without the need for hospital admission. The preference for ASCs stems from the expedited patient turnover, reduced risk of hospital-acquired infections, and their ability to provide specialized care. Hospitals serve as the primary setting for a wide range of endoscopic procedures, including capsule endoscopy. They are preferred for more complicated cases that require a multi-disciplinary approach or might require emergency intervention. Hospitals have a broad infrastructure that tends to incorporate various diagnostic and therapeutic services, which work in conjunction with capsule endoscopy outcomes if further treatment is needed.
Regional Insights
In the Americas, the United States is a key market for capsule endoscopy, driven by advanced healthcare infrastructure, a substantial focus on research and development, and a high prevalence of gastrointestinal diseases. The adoption of capsule endoscopy is supported by favorable reimbursement policies, less readily seen in other regions. Canada and South American countries also contribute to the market, though to a lesser extent due to variances in healthcare expenditure and technological adoption rates. The Asia-Pacific is witnessing rapid growth in the capsule endoscopy market, largely fueled by an increasing aging population, growing healthcare infrastructure, and rising incidences of gastrointestinal disorders. Countries such as Japan, South Korea, and China are at the forefront, with Japan featuring some of the earliest adopters of capsule endoscopy technology due to its innovation-friendly healthcare system. The Europe, Middle East, and Africa (EMEA) region presents a diverse market for capsule endoscopy. Western European countries have a mature healthcare sector with high adoption of novel diagnostic technologies, including capsule endoscopy, aided by strong healthcare systems and wide insurance coverage. In Middle Eastern countries, there is a growing demand for healthcare services and medical devices, including capsule endoscopy, driven by increasing healthcare investments and modernization of healthcare facilities.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Capsule Endoscopy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Capsule Endoscopy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Capsule Endoscopy Market, highlighting leading vendors and their innovative profiles. These include AdvinHealthcare, Ambu A/S, Anx Robotica Corp., Biocam Sp. z o.o., Boston Scientific Corporation, CapsoVision Inc., Check-Cap Ltd. by Symetryx Corp., Chongqing Jinshan Science & Technology (Group) Co., Ltd, Covestro AG, Duomed Group, Fujifilm Holding Corporation, Intromedic co., Ltd, Medtronic PLC, MU Ltd., Olympus Corporation, RF Systems Lab, Shangxian Minimal Invasive Inc., and STERIS Corporation.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Capsule Endoscopy Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Capsule Endoscopy Market?
3. What are the technology trends and regulatory frameworks in the Capsule Endoscopy Market?
4. What is the market share of the leading vendors in the Capsule Endoscopy Market?
5. Which modes and strategic moves are suitable for entering the Capsule Endoscopy Market?